Acasti Pharma Inc ACST

Here’s the problem

[boozehound3]

The failed strength trial is the bigger
problem.  No company will ever buy another fish oil krill
ool company again. Still no reason as to why that failed. I have said on the past this could be the biggest scam going. Epamova should
not have failed while vascepa works  !  Either they all work or
none work period.   secondary endpoints will be hard to meet statistically as they said they needed both trials to prove that. 

Yes capre works tomlower tg. But again who cares?

they will milk it along as the ceo makes over a million a year and I am sure doesn’t want to loose that pay

Good news is. I made more than isfuk nanildo. Ando. And blairman.  And Francine now for sure

[Rosmorduc]

The data shows that not only CAPRE works but it works exceptionally well. Look at the CAPRE data only witout the placebo or take the placebo from any other drug and you will see the hypocrisy.  The placebo from those 5 suspect sites are being investigated by the company and key outside experts. Once the study is reviewed with the FDA, the FDA will get this resolved as no placebo should have

[boozehound3]

No t arguing capre works to lower tg. It just won’t be proven like AMarin to reduce cv events.  It’s path closed with the epamova failure   No company will ever pay the Money needed for an outcome study    I bet if vascepa did one again it would fail to.   More money and studies will be needed.     The momentum has has been lost and it hard to get back

[Rosmorduc]

We shall see. A lot depends on what the FDA do when they will see the audit analysis.  ACST is convinced that the FDA will cooperate as it won't be able to turn their back to the audit analysis. The goal is to have the weight of those sites reduced or eliminated completely as it makes no sense. And there is an old saying: "when something doesn't make sense, it's not true

[EternalPonzi]

The true problem is no longer a clinical one but a fiscal one. Momentum and valuable time has been lost, perhaps irretrievably so, at what looks to be an absolutely dismal time. Even if Trilogy results satisfactorily explained the bursting of the 'everything' credit bubble has probably ruined any near term chance of a white knight purchasing the company based on the merit of the product

[postie1]

Bad timing is quite correct. Just hope that the problem can be solved. For those who believe that cornstarch is a miracle drug and works wonders , I would think that you would be buying into companies like Ingredion. After all is said and done,I do not believe anyone should substitute their medicine with cornstarch.(Bakker included)

[Rosmorduc]

Not really EternalPonzi. The company has clearly stated that they have enough cash to last them through this year. About 30M$ which is a lot for a company the size of ACST.  The company has also clearly stated that they have no plans for an equity offering or any other means of raising money as it's not necessary. I suggest you call Investor Relations and speak to them.  The

[EternalPonzi]

Yes they have about $30 million CDN (not US) and hopefully they will manage these financial resources well. However, they will need much more financing to successfully launch the product. The fact that the company says they have no plans to do something (or not) doesn't make it so. Many companies say and do things all the time that was unexpected in their self-interest. For example, one day a